Notably, NPAT has an important role in driving replication-dependent histone expression in breast cancers with cyclin E2 overexpression56, and germline NPAT mutations are a candidate risk factor for Hodgkin lymphoma, highlighting a role for excessive histone expression in tumorigenesis57. Here, CCNE2 is linked to breast carcinoma.